Literature DB >> 10204605

Higher frequencies of numerical aberrations of chromosome 17 in primary gastric cancers are associated with lymph node metastasis.

R Terada1, T Yasutake, E Yamaguchi, T Hisamatsu, S Nakamura, H Ayabe, Y Tagawa.   

Abstract

We investigated the correlation between the frequency of numerical aberrations of chromosome 17 and clinicopathological features of gastric cancer. The copy number of chromosome 17 was examined with fluorescence in-situ hybridization (FISH) in frozen specimens from 100 primary gastric cancers. Chromosomal numerical aberrations were diagnosed as chromosomal loss (single signal) or gain (triple or more signals), in each cell. The frequency of numerical aberrations of chromosome 17 correlated significantly with the depth of invasion (P < 0.01), lymph node metastasis (P < 0.0001), lymphatic invasion (P < 0.001), and venous invasion (P < 0.01). Numerical aberrations of chromosome 17 were associated with lymph node metastasis in 32 early gastric cancers. Multiple regression analysis identified the depth of invasion and numerical aberrations of chromosome 17 as independent significant determinants of lymph node metastasis. Our findings suggest that alterations in chromosome 17 may be linked with tumor progression in primary gastric cancer. Our results also indicate that numerical aberrations of chromosome 17 detected by FISH provide important information about the malignant potential (in particular, lymph node metastasis) of primary gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204605     DOI: 10.1007/s005350050210

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  7 in total

Review 1.  Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Authors:  Eiji Oki; Yuichi Hisamatsu; Koji Ando; Hiroshi Saeki; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

2.  Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer.

Authors:  Ryusuke Terada; Toru Yasutake; Shirou Nakamura; Takashi Hisamatsu; Terumitsu Sawai; Hiroyuki Yamaguchi; Tohru Nakagoe; Hiroyoshi Ayabe; Yutaka Tagawa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 3.  Chromosomal aberrations related to metastasis of human solid tumors.

Authors:  Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

4.  Chromosome 8 numerical aberrations in stage II invasive ductal carcinoma: correlation with patient outcome and poor prognosis.

Authors:  Yutaka Tagawa; Toru Yasutake; Yasushi Ikuta; Tadayuki Oka; Ryusuke Terada
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

5.  Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.

Authors:  Lian-Hai Zhang; Lun-Xiu Qin; Zeng-Chen Ma; Sheng-Long Ye; Yin-Kun Liu; Qing-Hai Ye; Xin Wu; Wei Huang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-07       Impact factor: 4.553

6.  Intratumor heterogeneity of centromere numerical abnormality in multiple primary gastric cancers: application of fluorescence in situ hybridization with intermittent microwave irradiation on paraffin-embedded tissue.

Authors:  K Kobayashi; Y Kitayama; H Igarashi; G Yoshino; T Kobayashi; T Kazui; H Sugimura
Journal:  Jpn J Cancer Res       Date:  2000-11

7.  Prohibitin expression deregulation in gastric cancer is associated with the 3' untranslated region 1630 C>T polymorphism and copy number variation.

Authors:  Mariana Ferreira Leal; Priscila Daniele Ramos Cirilo; Tatiane Katsue Furuya Mazzotti; Danielle Queiroz Calcagno; Fernanda Wisnieski; Samia Demachki; Margarita Cortes Martinez; Paulo Pimentel Assumpção; Roger Chammas; Rommel Rodríguez Burbano; Marília Cardoso Smith
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.